<DOC>
	<DOCNO>NCT01896492</DOCNO>
	<brief_summary>Polycystic ovary syndrome ( PCOS ) one common endocrine disorder , affect approximately 6-10 % woman reproductive age . Anovulation , infertility hyperandrogenism often co-exist hyperinsulinaemia insulin resistance . Clomiphene citrate remain standard drug induction augmentation ovulation . However , equally effective situation , therefore may require additional expensive drug N-acetyl cysteine , antioxidant , suggest adjuvant clomiphene-resistant case .NAC may also improve circulate level insulin insulin sensitivity hyperinsulinaemic woman PCOS , may useful treatment insulin resistance ameliorate homocysteine lipid profile PCOS .</brief_summary>
	<brief_title>Clomiphene Plus N-acetyl Cysteine Induction Ovulation Newly Diagnosed Pcos .</brief_title>
	<detailed_description>NAC use effectively adjuvant clomiphene citrate ( CC ) ovulation induction CC-resistant woman PCOS . Because insulin sensitizer , NAC propose adjuvant clomiphene citrate ovulation induction patient polycystic ovary syndrome resistant clomiphene citrate . Encouraging result patient stimulate u investigate whether add NAC standard treatment CC result high ovulation rate , high pregnancy rate , less CC resistance woman newly diagnose polycystic ovary syndrome use randomize , double-blind , control study .</detailed_description>
	<mesh_term>Clomiphene</mesh_term>
	<mesh_term>Enclomiphene</mesh_term>
	<mesh_term>Zuclomiphene</mesh_term>
	<mesh_term>Acetylcysteine</mesh_term>
	<mesh_term>N-monoacetylcystine</mesh_term>
	<mesh_term>Citric Acid</mesh_term>
	<criteria>PCOS diagnose Rotterdam 's criterion previous induction ovulation male factoe infertility tubal factor infertility uterine factor infertility</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>PCOS ,</keyword>
	<keyword>NAC ,</keyword>
	<keyword>OVULATION INDUCTION ,</keyword>
	<keyword>CLOMOPHEN CITRATE</keyword>
</DOC>